Albendazole treatment in cystic echinococcosis: Pharmacokinetics and clinical efficacy of two different aqueous formulations

Parasitology Research

Volumn 103, Issue 2, 2008, Pages 355-362

  Ceballos, Laura ^a,c   Elissondo, Celina ^b,c   Moreno, Laura ^a,c   Dopchiz, Marcela ^b,c   Sánchez Bruni, Sergio ^a,c   Denegri, Guillermo ^b,c   Alvarez, Luis ^a,c   Lanusse, Carlos ^a,c  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD NACIONAL DE MAR DEL PLATA   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFOXIDE; DRUG METABOLITE; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; ECHINOCOCCOSIS; ECHINOCOCCUS GRANULOSUS; HYDATID CYST; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUSPENSION; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT DURATION; TREATMENT RESPONSE;

ALBENDAZOLE; ANIMALS; ANTHELMINTICS; CHEMISTRY, PHARMACEUTICAL; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ECHINOCOCCOSIS; ECHINOCOCCUS GRANULOSUS; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; PHARMACEUTICAL SOLUTIONS; TREATMENT OUTCOME;

ANIMALIA; ECHINOCOCCUS GRANULOSUS; MUS;

EID: 44349168795     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-008-0980-x     Document Type: Article

References (33)

1. Ammann R, Eckert J (1995) Clinical diagnosis and treatment of echinococcosis in humans. In: Thompson RCA, Limbery AJ (eds) Echinococcus and hydatid disease. CAB International, Wallingford, UK, pp 441-463
2. Bartoloni C, Tricerri A, Guidi L, Gambassi G (1992) The efficacy of chemotherapy with mebendazole in human cystic echinococcosis: long-term follow-up of 52 patients. Ann Trop Med Parasitol 86:249-256
3. Castillo JA, Palomo-Canales J, García JJ, Lastres JL, Torrado JJ (1999) Preparation and characterization of albendazole b-cyclodextrin complexes. Drug Dev Ind Pharm 25:1241-1248
4. Ceballos L, Alvarez LI, Sanchez Bruni SF, Elissondo C, Dopchiz M, Denegri G, Torrado JJ, Lanusse CE (2006) Development of a cyclodextrin-based flubendazole formulation to control secondary echinococcosis: pharmacokinetics, hydatid cyst morphology and efficacy in mice. J Vet Pharmacol Ther 29:85-86
5. Davis A, Pawlowski ZS, Dixon H (1986) Multicenter trials of benzimidazole-carbamates in human echinococcosis. Bull World Health Organ 64:383-388
6. Davis A, Dixon H, Pawlowski ZS (1989) Multicentre clinical trials of benzimidazole carbamates in human cystic echinococcosis (phase 2). Bull World Health Organ 67:503-508
7. Dayan AD (2003) Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Trop 86:141-159
8. Eckert J, Deplazes P (2004) Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev 17:107-135
9. Elissondo C, Dopchiz M, Brasesco M, Denegri G (2004) Echinococcus granulosus: first report of microcysts formation from protoscoleces of cattle origin using the in vitro vesicular culture technique. Parasite 11:415-418
10. Elissondo C, Ceballos L, Dopchiz M, Andresiuk V, Alvarez LI, Sánchez Bruni SF, Lanusse CE, Denegri G (2007) In vitro and in vivo effects of flubendazole on Echinococcus granulosus metacestodes. Parasitol Res 100:1003-1009
11. El-On J (2003) Benzimidazole treatment of cystic echinococcosis. Acta Trop 85:243-252
12. Evrard B, Chiap P, DeTullio P, Ghalmid F, Piela G, Van Heesa T, Crommen J, Losson B, Delattre L (2002) Oral bioavailability in sheep of albendazole from a suspensión and from a solution containing hydroxypropyl-b- cyclodextrin. J Control Release 85:45-50
13. García JJ, Bolás F, Torrado JJ (2003) Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole. Int J Pharm 250:351-358
14. GarcIa-Rodriguez J, Torrado JJ, Bolas F (2001) Improving bioavailability and anthelmintic activity of albendazole by preparing albendazole-cyclodextrin complexes. Parasite 8:188-190
15. Gibaldi M, Perrier D (1982) Pharmacokinetics. Marcel Dekker, New York
16. Horton RJ (2003) Albendazole for the treatment of echinococcosis. Fundam Clin Pharmacol 17:205-212
17. Jenkins DJ, Romig T, Thompson RCA (2005) Emergence/re-emergence of Echinococcus spp.-a global update. Int J Parasitol 35:1205-1219
18. Kohri N, Yamayoshi Y, Xin H, Iseki K, Sato N, Todo S, Miyazaki K (1999) Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique. J Pharm Pharmacol 51:159-164
19. Lanusse CE, Prichard RK (1993) Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants. Drug Metab Rev 25:235-279
20. Menezes da Silva A (2003) Hydatid cyst of the liver-criteria for the selection of appropriate treatment. Acta Trop 85:237-242
21. Moro P, Schantz PM (2006) Cystic echinococcosis in the Americas. Parasitol Int 55:181-186
22. Pawlowski ZS, Eckert J, Vuitton DA, Ammann RW, Kern P, Craig PS et al (2001) Echinococcosis in humans: clinical aspects, diagnosis and treatment. In: Eckert J, Gemmell MA, Meslin FX, Pawlowski ZS (eds) WHO/OIE manual on echinococcosis in humans and animals: a public health problem of global concern. World Organisation for Animal Health, Paris, France
23. Recco P, Hornus E, Frejevus J, Micheau P, Bessieres MH, Roques C, Linas MD (1984) Hydatidose pleurale disseminee et hydatidoses hepatiquesTreatment post-operatoire par flubendazole a propos de 3 cas. Bull Soc Fr Parasitol 3:115-118
24. Rippman K, Dietrich M, Kern P (1992) Long-term therapy of cystic liver echinococcosis with mebendazole. Medizin Klin 87:350-354
25. Rodrigues JM, Bories C, Emery I, Fessi H, Devissaguet JP, Liance M (1995) Development of an injectable formulation of albendazole and in vivo evaluation of its efficacy against Echinococcus multilocularis metacestode. Int J Parasitol 12:1437-1441
26. Shuhua X, Jiqing Y, Mingjie W, Pieying J, Fanghua G, Junjie C, Wei J, Hotez P (2002) Augmented bioavailability and cysticidal activity of albendazole reformulated in soybean emulsion in mice infected with Echinococcus granulosus or Echinococcus multilocularis. Acta Trop 82:77-84
27. Stettler M, Rossignol JF, Fink R, Walker M, Gottstein B, Merli M, Theurillat R, Thormann W, Dricot E, Segers R, Hemphill A (2004) Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity. Int J Parasitol 34:615-624
28. Teggi A, Lastilla GM, De Rosa F (1993) Therapy of human hydatid disease with mebendazole and albendazole. Antimicrob Agents Chemother 37:1679-1684
29. Thompson D, Geary T (1995) The structure and function of helminth surfaces. In: Harr J, Muller M (eds) Biochemistry and molecular biology of parasites. Academic, London, UK
30. Todorov T, Mechkov G, Georgiev P, Handjiev S, Vutova K, Petkov D et al (1998) Chemotherapy of human cystic hydatid disease: indications, effectiveness, prognosis. Mediterr J Infect Parasitic Diseases 13:89-94
31. World Health Organization Informal Working Group on Echinococcosis (1996) Guideline for treatment of cysts and alveolar echinococcosis in human. Bull World Health Organ. Informal Working Group on Echinococcosis 74:231-242
32. World Health Organization Informal Working Group of Echinococcosis (2001) Puncture, aspiration, injection, re-aspiration. An option for the treatment of cystic echinococcosis. World Health Organization, Geneva, Switzerland, pp 1-40
33. Xiao SH, You JQ, Yang YQ, Guo HF, Zhang CW, Chai JJ, Zhang WL (1988) Histological alterations and drug concentrations in endocysts and cysts fluid of hydatid cysts harboring in mice treated with praziquantel. Acta Pharmacol Sin 9:461-464